Symbol: |
ORAI2
|
Description: |
ORAI calcium release-activated calcium modulator 2 [Source:HGNC Symbol;Acc:21667]
|
Location: |
Chr7:102073553-102097268[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:233
Gene |
Compound |
Gen_sig |
Exp_pattern |
ORAI2 |
RAPAMYCIN PRODRUG |
0.001 |
Down |
ORAI2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.005 |
Down |
ORAI2 |
Camptothecin lysinate HCl |
0.022 |
Down |
ORAI2 |
NSC 611229 |
0.042 |
Down |
ORAI2 |
Aspidospermin |
0.007 |
Down |
ORAI2 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.01 |
Down |
ORAI2 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfinyl)- |
0.031 |
Down |
ORAI2 |
NSC 6246 |
0.034 |
Down |
ORAI2 |
NSC 632780 |
0.013 |
Down |
ORAI2 |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.001 |
Down |
ORAI2 |
Disulfide, bis[2-amino-4-(4-methoxyphenyl)-1-methyl- 1H-imidazol-5-yl], dihydrochloride |
0.018 |
Down |
ORAI2 |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.001 |
Down |
ORAI2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.031 |
Down |
ORAI2 |
NSC 643836 |
0.047 |
Down |
ORAI2 |
Chlorodestruxin |
0.013 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:156
Total:11 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|